These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30878370)

  • 61. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical manifestation and related-risk factors analysis of chronic graft-versus-host disease].
    Weng JY; Du X; Lu ZS
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):168-70. PubMed ID: 23611230
    [No Abstract]   [Full Text] [Related]  

  • 63. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
    Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
    Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Blisters in a stem cell transplant patient.
    Griffin JR; Wetter DA; Camilleri MJ; Bridges AG
    Int J Dermatol; 2014 Feb; 53(2):142-4. PubMed ID: 23968164
    [No Abstract]   [Full Text] [Related]  

  • 65. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
    van Besien K; Hari P; Zhang MJ; Liu HT; Stock W; Godley L; Odenike O; Larson R; Bishop M; Wickrema A; Gergis U; Mayer S; Shore T; Tsai S; Rhodes J; Cushing MM; Korman S; Artz A
    Haematologica; 2016 May; 101(5):634-43. PubMed ID: 26869630
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation.
    Baron F; Labopin M; Niederwieser D; Vigouroux S; Cornelissen JJ; Malm C; Vindelov LL; Blaise D; Janssen JJ; Petersen E; Socié G; Nagler A; Rocha V; Mohty M
    Leukemia; 2012 Dec; 26(12):2462-8. PubMed ID: 22699419
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Allogeneic hematopoietic cell transplantation in adult patients with acute lymphoblastic leukemia.
    Marks DI; Alonso L; Radia R
    Hematol Oncol Clin North Am; 2014 Dec; 28(6):995-1009. PubMed ID: 25459175
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Minimal change disease in graft versus host disease: a podocyte response to the graft?
    Huskey J; Rivard C; Myint H; Lucia S; Smith M; Shimada M; Ishimoto T; Araya C; Garin EH; Johnson RJ
    Clin Nephrol; 2013 Dec; 80(6):469-73. PubMed ID: 23006339
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rituximab, fludarabine, and total body irradiation as conditioning regimen before allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukemia: long-term prospective multicenter study.
    Michallet M; Socié G; Mohty M; Sobh M; Bay JO; Morisset S; Labussière-Wallet H; Tabrizi R; Milpied N; Bordigoni P; El-Cheikh J; Blaise D
    Exp Hematol; 2013 Feb; 41(2):127-33. PubMed ID: 23089183
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Early central nervous system complications after reduced-intensity stem cell transplantation.
    Kishi Y; Miyakoshi S; Kami M; Ikeda M; Katayama Y; Murashige N; Kusumi E; Yuji K; Kobayashi K; Kato D; Hamaki T; Matsumura T; Kim SW; Morinaga S; Mori S; Kanemaru M; Hayashi T; Takaue Y; Taniguchi S;
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):561-8. PubMed ID: 15282534
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The role of hematopoietic stem cell transplantation in Chronic Lymphocytic Leukemia.
    Banerji V; Johnston JB; Seftel MD
    Transfus Apher Sci; 2007 Aug; 37(1):57-62. PubMed ID: 17919979
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ocular graft-versus-host disease: a review.
    Shikari H; Antin JH; Dana R
    Surv Ophthalmol; 2013; 58(3):233-51. PubMed ID: 23541042
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome.
    Skert C; Patriarca F; Sperotto A; Cerno M; Filì C; Zaja F; Stocchi R; Geromin A; Damiani D; Fanin R
    Haematologica; 2006 Feb; 91(2):258-61. PubMed ID: 16461315
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The prevalence and prognostic value of concomitant eosinophilia in chronic graft-versus-host disease after allogeneic stem cell transplantation.
    Mortensen KB; Gerds TA; Bjerrum OW; Lindmark A; Sengeløv H; Andersen CL
    Leuk Res; 2014 Mar; 38(3):334-9. PubMed ID: 24439053
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation.
    Erturk SM; Mortelé KJ; Binkert CA; Glickman JN; Oliva MR; Ros PR; Silverman SG
    AJR Am J Roentgenol; 2006 Jun; 186(6):1497-501. PubMed ID: 16714636
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation.
    Fujii N; Takenaka K; Shinagawa K; Ikeda K; Maeda Y; Sunami K; Hiramatsu Y; Matsuo K; Ishimaru F; Niiya K; Yoshino T; Hirabayashi N; Harada M
    Bone Marrow Transplant; 2001 May; 27(9):1007-10. PubMed ID: 11436113
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
    Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Progressive multifocal leukoencephalopathy: a rare infectious complication following allogeneic hematopoietic cell transplantation (HCT).
    Kaufman GP; Aksamit AJ; Klein CJ; Yi ES; Delone DR; Litzow MR
    Eur J Haematol; 2014 Jan; 92(1):83-7. PubMed ID: 24118404
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia: a way to improve the outcome?
    Niscola P; Cupelli L; Dentamaro T; de Fabritiis P
    Leuk Res; 2016 Mar; 42():80-1. PubMed ID: 26790726
    [No Abstract]   [Full Text] [Related]  

  • 80. The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Rubio MT; Labopin M; Blaise D; Socié G; Contreras RR; Chevallier P; Sanz MA; Vigouroux S; Huynh A; Shimoni A; Bulabois CE; Caminos N; López-Corral L; Nagler A; Mohty M
    Haematologica; 2015 May; 100(5):683-9. PubMed ID: 25769546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.